Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors (2020)
- Authors:
- USP affiliated authors: TROSSINI, GUSTAVO HENRIQUE GOULART - FCF ; DIAS, MARCIO VINÍCIUS BERTACINE - ICB ; PARISE FILHO, ROBERTO - FCF ; FERREIRA, GLAUCIO MONTEIRO - FCF
- Unidades: FCF; ICB
- DOI: 10.1016/j.bmc.2020.115600
- Subjects: MICROBIOLOGIA; METABÓLITOS; ÁCIDOS CARBOXÍLICOS; DNA; TUBERCULOSE; CINÉTICA QUÍMICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Bioorganic & Medicinal Chemistry
- ISSN: 1464-3391
- Volume/Número/Paginação/Ano: v. 28, n. 15, art. 115600, 10 p., 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
KRONENBERGER, Thales et al. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors. Bioorganic & Medicinal Chemistry, v. 28, n. 15, p. 10 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bmc.2020.115600. Acesso em: 28 dez. 2025. -
APA
Kronenberger, T., Ferreira, G. M., Souza, A. D. F. de, Santos, S. da S., Poso, A., Ribeiro, J. A., et al. (2020). Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors. Bioorganic & Medicinal Chemistry, 28( 15), 10 . doi:10.1016/j.bmc.2020.115600 -
NLM
Kronenberger T, Ferreira GM, Souza ADF de, Santos S da S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise Filho R. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 15): 10 .[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.bmc.2020.115600 -
Vancouver
Kronenberger T, Ferreira GM, Souza ADF de, Santos S da S, Poso A, Ribeiro JA, Tavares MT, Pavan FR, Trossini GHG, Dias MVB, Parise Filho R. Design, synthesis and biological activity of novel substituted 3-benzoic acid derivatives as MtDHFR inhibitors [Internet]. Bioorganic & Medicinal Chemistry. 2020 ; 28( 15): 10 .[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.bmc.2020.115600 - Optimization of new dihydrofolate reductase inhibitors of mycobacterium tuberculosis (mtDHFR): molecular docking, synthesis, evaluation of enzyme inhibition and antimycobacterial activity
- Using a fragment-based approach to identify alternative chemical scaffolds targeting dihydrofolate reductase from Mycobacterium tuberculosis
- Antiglioblastoma potential of N-benzyl-naphtylamines: synthesis, biological evaluation and molecular modeling
- Arylsulfonylhydrazone induced apoptosis in MDA-MB-231 breast cancer cells
- Toward chelerythrine optimization: Analogues designed by molecular simplification exhibit selective growth inhibition in non-small-cell lung cancer cells
- Abordagem estrutural sobre biossínteses, alvos, estratégias de desenvolvimento e resistência a antimicrobianos
- Mycobacterial OtsA structures unveil substrate preference mechanism and allosteric regulation by 2-oxoglutarate and 2-phosphoglycerate
- Enzymology of pyran ring A formation in salinomycin biosynthesis
- Structural basis of the selectivity of GenN, an Aminoglycoside N-Methyltransferase involved in gentamicin biosynthesis
- Cloning, expression, purification and biophysical analysis of two putative halogenases from the glycopeptide A47,934 gene cluster of Streptomyces toyocaensis
Informações sobre o DOI: 10.1016/j.bmc.2020.115600 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
